{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T17:37:06Z","timestamp":1785173826091,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA201487"],"award-info":[{"award-number":["R01CA201487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA201487"],"award-info":[{"award-number":["R01CA201487"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA128919"],"award-info":[{"award-number":["R01CA128919"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer patients who undergo regional nodal irradiation therapy (RNI) following neoadjuvant chemotherapy and mastectomy or lumpectomy with axillary lymph node dissection (ALND) frequently encounter breast cancer-related lymphedema (BCRL). Early detection and treatment can significantly improve outcomes. Previously, near-infrared fluorescence lymphatic imaging (NIRF-LI) detection of dermal backflow, or retrograde lymphatic flow into initial lymphatics, was shown to precede clinical BCRL diagnosis by 8\u201323 months. Herein, we hypothesize that lymphatic pump failure is responsible for dermal backflow and may be a target to prevent onset of BCRL symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Arm lymphatics in 51 patients with locally advanced breast cancer were visualized with NIRF-LI in a prospective, longitudinal, observational clinical cohort study. Lymphatic pumping frequencies were measured to investigate pumping changes during and after breast cancer treatment. Lymphatic pumping was quantified at five timepoints: after neoadjuvant chemotherapy, but before breast cancer excision and ALND, again at four weeks post-ALND, and at 6, 12, and 18 months post-RNI. Repeated measures mixed-effects analysis was used to compare the mean pumping frequencies amongst all time points. Additionally, pairwise comparisons between any two time points were performed using Wilcoxon matched-pairs signed rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>As time lapsed after surgical treatment and RNI, ipsilateral dorsal forearm, ipsilateral ventral forearm, and ventral axilla pumping failure preceded the appearance of dermal backflow and clinically diagnosed BCRL, suggesting that lymphatic pumping dysfunction is the first step in BCRL development.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study suggests that impairment of the intrinsic lymph pump may be responsible for the onset of clinical BCRL symptoms, and therefore represents a target for prevention of cancer-acquired lymphedema. Future research is needed to understand the molecular determinants of the intrinsic lymphatic pump, and how cancer treatments and interventions can impact them.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13058-026-02231-w","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T08:24:58Z","timestamp":1771316698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lymphatic pumping failure in the arm precedes dermal backflow and breast cancer-related lymphedema"],"prefix":"10.1186","volume":"28","author":[{"given":"Melissa B.","family":"Aldrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan E.","family":"McWain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona F.","family":"Shaitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rian E.","family":"Kuhns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A.","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"DeSnyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyaw","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva M.","family":"Sevick-Muraca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"2231_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.21037\/gs.2017.11.04","volume":"7","author":"TC Gillespie","year":"2018","unstructured":"Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7:379\u2013403. https:\/\/doi.org\/10.21037\/gs.2017.11.04. PMID: 30175055 PMCID: PMC6107585.","journal-title":"Gland Surg"},{"key":"2231_CR2","first-page":"3","volume":"53","author":"Executive Committee of the International Society of Lymphology","year":"2020","unstructured":"Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology. 2020;53:3\u201319. PMID: 32521126.","journal-title":"Lymphology"},{"key":"2231_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1200\/OP.23.00060","volume":"19","author":"J Boyages","year":"2023","unstructured":"Boyages J, Vicini FA, Manavi BA, Gaw RL, Koelmeyer LA, Ridner SH, Shah C. Axillary treatment and chronic breast cancer-related lymphedema: implications for prospective surveillance and intervention from a randomized controlled trial. JCO Oncol Pract. 2023;19:1116\u201324. https:\/\/doi.org\/10.1200\/OP.23.00060. PMID: 37816208 PMCID: PMC10732511.","journal-title":"JCO Oncol Pract"},{"key":"2231_CR4","doi-asserted-by":"publisher","unstructured":"Naoum GE, Roberst S, Brunelle CL, Shue AM, Salama L, Daniell K, Gillespie T, Bucci L, Smith BL, Ho AY, Taghian AG. Quantifying the impact of axillary surgery and nodal irradiation on breast cancer-related lymphedema and local tumor control: long-term results from a prospective screening trial. J Clin Oncol. 2020;38:3440\u201338. PMID: 32730184 https:\/\/doi.org\/10.1200\/JCO.20.00459","DOI":"10.1200\/JCO.20.00459"},{"key":"2231_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1177\/1358863X15620852","volume":"21","author":"SG Rockson","year":"2016","unstructured":"Rockson SG, Lymphedema. Vasc Med. 2016;21:77\u201381. PMID: 26819350 doi: 10.1177\/1358863X15620852.","journal-title":"Vasc Med"},{"key":"2231_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10549-016-4089-0","volume":"162","author":"SF Shaitelman","year":"2017","unstructured":"Shaitelman SF, Chiang Y-J, Griffin KD, DeSnyder SM, Smith BD, Schaverien MV, Woodward WA, Cormier. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis. Breast Cancer Res Treat. 2017;162:201\u201315. https:\/\/doi.org\/10.1007\/s10549-016-4089-0.","journal-title":"Breast Cancer Res Treat"},{"key":"2231_CR7","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijrobp.2023.04.020","volume":"117","author":"GE Naoum","year":"2023","unstructured":"Naoum GE, Taghian AG. Regional lymph node radiation is not the main risk factor for breast cancer-related lymphedema: stop chasing radiation doses, fractionation or techniques\u2014focus on axillary surgery de-escalation or prevention. Int J Radiat Oncol Biol Phys. 2023;117:461\u20134.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2231_CR8","doi-asserted-by":"publisher","unstructured":"Rafn BS, Christensen J, Larsen A, Bloomquist K. Prospective surveillance for breast cancer-related arm lymphedema: a systematic review and meta-analysis. J Clin Oncol. 2022;40:1009-26. PMID: 35077194. https:\/\/doi.org\/10.1200\/jco.21.01681","DOI":"10.1200\/jco.21.01681"},{"key":"2231_CR9","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1002\/cncr.23494","volume":"12","author":"NL Stout Gergich","year":"2008","unstructured":"Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;12:2809\u201319. https:\/\/doi.org\/10.1002\/cncr.23494. PMID: 18428212.","journal-title":"Cancer"},{"key":"2231_CR10","doi-asserted-by":"publisher","unstructured":"Can AG, Ek\u015fio\u011flu E, \u00c7ak\u00e7i FA. Early detection and treatment of subclinical lymphedema in patients with breast cancer. Lymph Res Biol. 2019;17: 68\u201373. PMID: 30543479 https:\/\/doi.org\/10.1089\/lrb.2018.0033","DOI":"10.1089\/lrb.2018.0033"},{"key":"2231_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10549-033-06667-4","volume":"195","author":"MB Aldrich","year":"2022","unstructured":"Aldrich MB, Rasmussen JC, DeSnyder SM, Woodward WA, Chan W, Sevick-Muraca EM, Mittendorf EA, Smith BD, Stauder MC, Strom EA, Perkins GH, Hoffman KE, Mitchell MP, Barcenas CH, Isales LE, Shaitelman SF. Prediction of breast cancer-related lymphedema by dermal backflow detected with near-infrared fluorescence lymphatic imaging. Breast Cancer Res Treat. 2022;195:33\u201341. https:\/\/doi.org\/10.1007\/s10549-033-06667-4. PMID: 35816269 PMCID: PMC9272652 doi:.","journal-title":"Breast Cancer Res Treat"},{"key":"2231_CR12","doi-asserted-by":"publisher","unstructured":"Von der Weid P-Y, Zawieja DC. Lymphatic smooth muscle: the motor unit of lymph drainage. Int J Biochem Cell Biol. 2004;36:1147-53. PMID: 15109561 https:\/\/doi.org\/10.1016\/j.biocel.2003.12.008","DOI":"10.1016\/j.biocel.2003.12.008"},{"key":"2231_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.mvr.2014.07.013","volume":"96","author":"JW Breslin","year":"2014","unstructured":"Breslin JW. Mechanical forces and lymphatic transport. Microvasc Res. 2014;96:46\u201354. https:\/\/doi.org\/10.1016\/j.mvr.2014.07.013. PMID: 25107458 PMCID: PMC4267889.","journal-title":"Microvasc Res"},{"key":"2231_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1146\/annurev-fluid-122316-045259","volume":"50","author":"JE Moore Jr","year":"2018","unstructured":"Moore JE Jr., Bertram CD. Lymphatic system flows. Annu Rev Fluid Mech. 2018;50:459\u201382. https:\/\/doi.org\/10.1146\/annurev-fluid-122316-045259. PMID: 29713107 PMCID: PMC5922450.","journal-title":"Annu Rev Fluid Mech"},{"key":"2231_CR15","doi-asserted-by":"crossref","unstructured":"Scallan JP, Zawieja SD, Castorena-Gonzalez JA, Davis MJ. Lymphatic pumping: mechanics, mechanisms and malfunction. (2016). J Physiol 594:5749\u201368. PMID: 27219461 PMCID: PMC5063934 doi: 10.1113\/JP272088.","DOI":"10.1113\/JP272088"},{"key":"2231_CR16","doi-asserted-by":"publisher","unstructured":"Razavi MS, Munn LL, Padera TP. Mechanics of lymphatic pumping and lymphatic function. Cold Spring Harb Perspect Med. 2024;a041171. https:\/\/doi.org\/10.1101\/cshperspect.a041171. PMID: 38692743.","DOI":"10.1101\/cshperspect.a041171"},{"key":"2231_CR17","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ijrobp.2019.07.054","volume":"105","author":"S Kwon","year":"2019","unstructured":"Kwon S, Janssen CF, Velasquez FC, Zhang S, Aldrich MB, Shaitelman SF, DeSnyder SM, Sevick-Muraca EM. Radiation dose-dependent changes in lymphatic remodeling. Int J Radiat Oncol Biol Phys. 2019;105:852\u201360. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.07.054.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2231_CR18","doi-asserted-by":"publisher","unstructured":"Zawieja SD, Pea GA, Broyhill SE, Patro A, Bromert KH, Norton CE, Kim HJ, Sivasankaran SK, Li M, Castorena-Gonzalez JA, Drumm BT, Davis MJ. Cellular characterization of the mouse collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells. eLife. 2025;12:RP90679. https:\/\/doi.org\/10.7554\/eLife.90679.","DOI":"10.7554\/eLife.90679"},{"key":"2231_CR19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1089\/lrb.2009.0007","volume":"7","author":"DC Zawieja","year":"2009","unstructured":"Zawieja DC. Contractile physiology of lymphatics. Lymphat Res Biol. 2009;7:87\u201396. https:\/\/doi.org\/10.1089\/lrb.2009.0007. PMCID: PMC2925033.","journal-title":"Lymphat Res Biol"},{"key":"2231_CR20","doi-asserted-by":"publisher","first-page":"676","DOI":"10.3390\/cancers15030676","volume":"15","author":"AR Vang","year":"2023","unstructured":"Vang AR, Shaitelman SF, Rasmussen JC, Chan W, Sevick-Muraca, Aldrich MB. Plasma cytokines\/chemokines as predictive biomarkers for lymphedema in breast cancer patients. Cancers. 2023;15:676. https:\/\/doi.org\/10.3390\/cancers15030676. PMID: 36765631 PMCID: PMC9913278.","journal-title":"Cancers"},{"key":"2231_CR21","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1016\/j.prro.1012.10.008","volume":"14","author":"AK Yoder","year":"2023","unstructured":"Yoder AK, Xu T, Youssef P, DeSnyder SM, Marqueen KE, Isales L, Lin R, Smith BD, Woodward WA, Stauder MC, Strom EA, Aldrich MB, Shaitelman SF. Association between symptom burden and early lymphatic abnormalities after regional nodal irradiation for breast cancer. Pract Radiat Oncol. 2023;14:e180\u20139. https:\/\/doi.org\/10.1016\/j.prro.1012.10.008.","journal-title":"Pract Radiat Oncol"},{"key":"2231_CR22","doi-asserted-by":"publisher","unstructured":"Rasmussen JC, Tan I-C, Marshall MV, Adams KE, Kwon S, Fife CE, Maus EA, Smith LA, Covington KR, Sevick-Muraca EM. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Transl Oncol. 2010;3: 362\u201372. PMID: 21151475 PMCID: PMC3000461 https:\/\/doi.org\/10.1593\/tlo.10190","DOI":"10.1593\/tlo.10190"},{"key":"2231_CR23","doi-asserted-by":"publisher","unstructured":"Naoum GE, Oladenu O, Ababneh H, Shui A, Ly Am, Taghian AG. Pathologic exploration of the axillary soft tissue microenvironment and its impact on axillary management and breast cancer outcomes. J Clin Oncol. 2024;42:157\u2013169. https:\/\/doi.org\/10.1200\/JCO.23.01009","DOI":"10.1200\/JCO.23.01009"},{"key":"2231_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ijrobp.2024.04.073","volume":"120","author":"O Koleoso","year":"2024","unstructured":"Koleoso O, Toumbacaris N, Brogi E, Zhang Z, Braunstein LZ, Morrow M, Moo T-A, El-Tamer M, Marine CB, Powell SN, Khan AJ. The presence of extensive lymphovascular invasion is associated with higher risks of local-regional recurrence compared with usual lymphovascular invasion in curatively treated breast cancer patients. Int J Radiat Oncol Biol Phys. 2024;120:835\u201344. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.04.073.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2231_CR25","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/cncr.34352","volume":"128","author":"AMC Sittenfeld","year":"2022","unstructured":"Sittenfeld AMC, Zabor EC, Hamilton SN, Kuerer HM, El-Tamer M, Naoum GE, Truong PT, Nichol A, Smith BD, Woodward WA, Moo T-A, Powell SN, Shah CS, Taghian AG, Abu-Gheida I, Tendulkar RD. A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer. Cancer. 2022;128:3057\u201366. https:\/\/doi.org\/10.1002\/cncr.34352.","journal-title":"Cancer"},{"key":"2231_CR26","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1186\/s12885-018-4851-2","volume":"18","author":"M Invernizzi","year":"2018","unstructured":"Invernizzi M, Corti C, Lopez G, Michelotti A, Despini L, Gambini D, Lorenzini D, Guerini-Rocco E, Maggi S, Noale M, Fusco N. Lymphovascular invasion and extranodal tumour extension Ae risk indicators of breast cancer related lymphoedema: an observational retrospective study with long-term follow-up. BMC Cancer. 2018;18:935. https:\/\/doi.org\/10.1186\/s12885-018-4851-2.","journal-title":"BMC Cancer"},{"key":"2231_CR27","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.3390\/ijms21072546","volume":"21","author":"CY Li","year":"2020","unstructured":"Li CY, Kataru RP, Mehrara BJ. Histopathologic features of lymphedema: a molecular review. J Mol Sci. 2020;21:2546. https:\/\/doi.org\/10.3390\/ijms21072546. PMID: 32268536 PMCID: PMC7177532.","journal-title":"J Mol Sci"},{"key":"2231_CR28","doi-asserted-by":"publisher","unstructured":"Stolarz A, Sarimollaoglu M, Marecki JC, Fletcher TW, Galanzha EI, Rhee SW, Zharov VP, Klimberg VS, rusch NJ. Doxorubicin activates Ryanodine receptors in rat lymphatic muscle cells to attenuate rhythmic contractions and lymph flow. J Pharmacol Exp Ther. 2019;371:278\u201389. PMID: 31439806 PMCID: PMC6815939 https:\/\/doi.org\/10.1124\/jpet.119.257592","DOI":"10.1124\/jpet.119.257592"},{"key":"2231_CR29","doi-asserted-by":"publisher","unstructured":"Jia M, Pan L, Yang H, Gao J, Guo F. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study. Breast Cancer Res Treat. Online ahead Print PMID: 38097882. 2023. https:\/\/doi.org\/10.1007\/s10549-023-07183-9.","DOI":"10.1007\/s10549-023-07183-9"},{"key":"2231_CR30","doi-asserted-by":"publisher","first-page":"727526","DOI":"10.3389\/fphar.2021.717526","volume":"12","author":"S Van","year":"2021","unstructured":"Van S, Pal S, Garner BR, Steed K, Sridharan V, Mu S, Rusch NJ, Stolarz AJ. Dantrolene prevents the lymphostasis caused by doxorubicin in the rat mesenteric circulation. Front Pharmacol. 2021;12:727526. https:\/\/doi.org\/10.3389\/fphar.2021.717526. PMID: 34483938 PMCID: PMC8415554.","journal-title":"Front Pharmacol"},{"key":"2231_CR31","doi-asserted-by":"publisher","unstructured":"Danielsen TK, Sadredini M, Manotheepan R, Aronsen JM, Frisk M, Hansen MH, Andressen KW, Hougen K, Levy FO, Louch WE, Sejersted OM, Sjaastad I, Stokke MK. Exercise training stabilizes RyR2-dependent Ca2\u2009+\u2009release in post-infarction heart failure. Front Cardiovasc Med. 2021;25:7:623922 PMID: 33569394 PMCID: PMC7868397 https:\/\/doi.org\/10.3389\/fcvm.2020.623922","DOI":"10.3389\/fcvm.2020.623922"},{"key":"2231_CR32","doi-asserted-by":"publisher","unstructured":"Shao C-H, Wehrens XHT, Wyatt TA, Parbhu S, Rozanski GJ, Patel KP, Bidasee KR. Exercise training during diabetes attenuates cardiac Ryanodine receptor dysregulation. J Appl Physiol. 2009;106:1280\u201392. PMID: 19131475 PMCID: PMC2698642 https:\/\/doi.org\/10.1152\/japplphysiol.91280.2008","DOI":"10.1152\/japplphysiol.91280.2008"},{"key":"2231_CR33","doi-asserted-by":"publisher","unstructured":"Aldrich MB, Sevick-Muraca EM. Cytokines are systemic effectors of lymphatic function in inflammation. Cytokine. 2013;64:362-9. https:\/\/doi.org\/10.1016\/j.cyto.2013.05.015","DOI":"10.1016\/j.cyto.2013.05.015"},{"key":"2231_CR34","doi-asserted-by":"publisher","first-page":"6370","DOI":"10.1245\/s10434-022-12142-7","volume":"29","author":"CR Farley","year":"2022","unstructured":"Farley CR, Irwin S, Adesoye T, Sun SX, DeSnyder SM, Lucci A, Shaitelman SF, Chang EI, Ueno NT, Woodward WA, Teshome M. Lymphedema in inflammatory breast cancer patients following trimodal treatment. Ann Surg Oncol. 2022;29:6370\u20138. https:\/\/doi.org\/10.1245\/s10434-022-12142-7. PMID: 35854031.","journal-title":"Ann Surg Oncol"},{"key":"2231_CR35","doi-asserted-by":"publisher","unstructured":"Alstrup M, Johannessen AL, Mohanakumar S, Offersen BV, Hjortdal VE. Lymphatic function in the arms of breast cancer patients\u2014a prospective cohort study. Plast Reconstr Surg Glob Open. 2021;9:e3779 PMID: 34476161 PMCID: PMC8386902 https:\/\/doi.org\/10.1097\/GOX.0000000000003779","DOI":"10.1097\/GOX.0000000000003779"},{"key":"2231_CR36","doi-asserted-by":"publisher","first-page":"e4507","DOI":"10.1097\/GOX.0000000000004507","volume":"10","author":"AL Johannessen","year":"2022","unstructured":"Johannessen AL, Alstrup M, Hjortdal VE, Offersen BV, Mohanakumar S. Lymphatic function decreases over time in the arms of breast cancer patients following treatment. Plast Reconstr Surg Glob Open. 2022;10:e4507. https:\/\/doi.org\/10.1097\/GOX.0000000000004507. PMID: 36128434 PMCID: PMC9481438.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2231_CR37","doi-asserted-by":"publisher","unstructured":"Granoff MD, Fleishman A, Shillue K, Johnson AR, Ross J, Lee BT, Teller P, James TA, Singhal D. A 4-year institutional experience of immediate lymphatic reconstruction. Plast Reconstr Surg. 2023;152:773e-778e. PMID: 36877759 https:\/\/doi.org\/10.1097\/PRS.00000000000010381","DOI":"10.1097\/PRS.00000000000010381"},{"key":"2231_CR38","doi-asserted-by":"publisher","unstructured":"Buchan G, Cakmakoglu C, Schwarz GS. ICG lymphographic findings following immediate lymphatic reconstruction in breast cancer patients. J Plast Reconstr Aesthet Surg. 2022;75:2164-71. PMCID 35370229 https:\/\/doi.org\/10.1016\/j.bjps.2022.02.020.","DOI":"10.1016\/j.bjps.2022.02.020"},{"key":"2231_CR39","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1245\/s10434-024-15715-w","volume":"31","author":"JW Jakub","year":"2024","unstructured":"Jakub JW, Boughey JC, Hieken TJ, Piltin M, Forte AJ, Vijayasekaran A, Mazur M, Sturz J, Corbin K, Vallow L, Johnson JE, Mrdutt M, Fahradyan V, Li Z, Blumenfeld S, Degnim A, Yost KJ, Cheville A, McLaughlin SA. Lymphedema rates following axillary lymph node dissection with and without immediate lymphatic reconstruction: a prospective trial. Ann Surg Oncol. 2024;31:7349\u201359. https:\/\/doi.org\/10.1245\/s10434-024-15715-w.","journal-title":"Ann Surg Oncol"},{"key":"2231_CR40","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1101\/gad.1955910","volume":"24","author":"Y Wang","year":"2010","unstructured":"Wang Y, Oliver G. Current views on the function of the lymphatic vasculature in health and disease. Genes Dev. 2010;24:2115\u20136. https:\/\/doi.org\/10.1101\/gad.1955910. PMID: 20889712 PMCID: PMC2947764.","journal-title":"Genes Dev"},{"key":"2231_CR41","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/PRS.0b013e3182268cd9","volume":"128","author":"T Yamamoto","year":"2011","unstructured":"Yamamoto T, Yamamoto N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I. Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg. 2011;128:941\u20137. 0.1097\/PRS.0b013e3182268cd9.","journal-title":"Plast Reconstr Surg"},{"key":"2231_CR42","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10911-023-09545-x","volume":"18","author":"JR Kinney","year":"2023","unstructured":"Kinney JR, Friedman R, Kim E, Tillotson E, Shillue K, Lee BT, Singhal D. Non-linear lymphatic anatomy in breast cancer patients prior to axillary lymph node dissection: a risk factor for lymphedema development. J Mammary Gland Biol Neoplasia. 2023;18:20. https:\/\/doi.org\/10.1007\/s10911-023-09545-x.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"2231_CR43","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jama.2017.11470","volume":"318","author":"AE Giuliano","year":"2017","unstructured":"Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M. Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and Sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial. JAMA. 2017;318:918\u201326. https:\/\/doi.org\/10.1001\/jama.2017.11470.","journal-title":"JAMA"},{"key":"2231_CR44","doi-asserted-by":"publisher","unstructured":"Rasmussen JC, Tan IC, Marshall MV, Adams KE, Kwon S, Fife CE, Maus EA, Smith LA, Covington KR, Sevick-Muraca EM. Human lymphatic architecture and dynamic transport imaged using near-infrared fluorescence. Transl Oncol.2010;3:362\u201372. PMID: 21151475 https:\/\/doi.org\/10.1593\/tlo.10190.","DOI":"10.1593\/tlo.10190"},{"key":"2231_CR45","doi-asserted-by":"publisher","unstructured":"Ma W, Gil HJ, Escobedo N, Benito-Martin A, Ximenez-Embun P, Munoz J, Peinado H, Rockson SG, Oliver G. Platelet factor 4 is a biomarker for lymphatic-promoted disorders. JCI Insight. 2020;5:e135109. PMID: 32525843 https:\/\/doi.org\/10.1172\/jci.insight.135109.","DOI":"10.1172\/jci.insight.135109"},{"key":"2231_CR46","doi-asserted-by":"publisher","unstructured":"Tian W, Rockson SG, Jiang X, Kim J, Begaye A, Shuffle EM, Tu AB, Cribb M, Nepiyushchikh Z, Feroze AH, Zamanian RT, Dhillon GS, Voelkel NF, Peters-Golden M, Kitajewski J, Dixon JB, Nicolls MR. Leukotriene B4 antagonism ameliorates experimental lymphedema. Sci Transl Med. 2017;9:eaa13920. PMID: 28490670 https:\/\/doi.org\/10.1126\/scitranslmed.aal3920.","DOI":"10.1126\/scitranslmed.aal3920"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13058-026-02231-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02231-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-026-02231-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:22:00Z","timestamp":1781634120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13058-026-02231-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2231"],"URL":"https:\/\/doi.org\/10.1186\/s13058-026-02231-w","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Signed informed consent was obtained from all study subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}